1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Aneurysm characteristics among patients who either presented with a visual disturbance or developed one after treatmenta
Variable Improved (n = 15) Not Improved or Worse (n = 8) P Value Aneurysm size 7.7 ± 5.2 11.9 ± 5.1 .082 Neck diameter 3.2 ± 1.5 5.3 ± 1.6 .009 Dome-to-neck ratio 2.09 ± 1.1 2.2 ± 0.7 .738 Packing attenuation 28.6 ± 13.7 27.1 ± 10.1 .773 Requiring retreatment 2 (13%) 4 (50%) .131
↵a There are 23 total patients because 1 patient developed a new visual disturbance after treatment.